Skip to content
Home/Companies/MedTech/Inventis
Inventis

Inventis

MedTech·Italy·Exited 2022·Held 4yr
Entry
2018
Hold
4yr
Exit
2022

Who owns Inventis?

Inventis was owned by Innovative-RFK through Innovative-RFK (2017 vintage) from 2018 to 2022.

Hand-verified · updated 2026-07-31

Innovative-RFK
Investor
Innovative-RFK
Innovative-RFK · 2017 · Buyout

Key facts

HQItaly
SectorMedTech
StatusAcquired
Websitewww.inventis.it
Exit Type
–
Buyer
–
MOIC
Exit Year
2022

More from Innovative-RFK

Other portfolio companies in the same fund.

Abbrevia
Abbrevia
Active
Business ServicesItaly· 2023
Audio Technologies
Audio Technologies
Active
MedTechItaly· 2023
Magilla
Magilla
Exited 2024
AdTechItaly· 2022
to
Hyntelo
Hyntelo
Exited 2025
AI/MLItaly· 2021
to
Red Raion
Exited 2024
TMTItaly· 2021
Reaxing
Reaxing
Active
ConsumerItaly· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Inventis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Inventis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue